scispace - formally typeset
R

Ravindra K. Pandey

Researcher at University of California, Davis

Publications -  74
Citations -  1591

Ravindra K. Pandey is an academic researcher from University of California, Davis. The author has contributed to research in topics: Porphyrin & Heme. The author has an hindex of 22, co-authored 74 publications receiving 1571 citations. Previous affiliations of Ravindra K. Pandey include Roswell Park Cancer Institute & University of Rome Tor Vergata.

Papers
More filters
Journal ArticleDOI

Synthesis, photophysical properties, in vivo photosensitizing efficacy, and human serum albumin binding properties of some novel bacteriochlorins

TL;DR: In preliminary in vivo studies, ketobacteriochlorins were found to be more photodynamically active than the related vic-dihydroxy analogues and replacement of the methyl ester functionalities with di-tert-butylaspartic acids enhanced the in vivo efficacy.
Patent

Pyropheophorbides and their use in photodynamic therapy

TL;DR: The pyropheophorbide compounds are injected into a host and accumulate in tumor tissue to a higher degree than surrounding normal tissues as discussed by the authors, and they absorb light further in the red, optimizing tissue penetration.
Journal ArticleDOI

Comparative analysis of the conformations of symmetrically and asymmetrically deca- and undecasubstituted porphyrins bearing meso-alkyl or -aryl groups

TL;DR: Spectrosopic studies suggest that conformations similar to those determined by X-ray crystallography are present in solution for the 5,15-dialkyl- and 5, 15-diaryl-substituted porphyrins.
Journal ArticleDOI

Stepwise syntheses of bisporphyrins, bischlorins, and biscorroles, and of porphyrin-chlorin and porphyrin-corrole heterodimers

TL;DR: In this paper, a series of symmetrical and unsymmetrical bisporphyrins, bischlorins, and biscorroles, and of porphyrin−chlorin and porphrin−corrole dyads possessing ethylene, phenyl, and stilbene linking units are described.
Patent

Pyropheophorbides conjugates and their use in photodynamic therapy

TL;DR: The pyropheophorbide compounds have been shown to have a variety of characteristics when used in photodynamic therapy as mentioned in this paper, and these characteristics are further improved when the compounds are bound to a target specific component such as a ligand capable of binding to a specific cellular receptor (e.g. growth hormones and growth factors) or an antibody capable of Binding to a particular antigen.